With defamation of characters and misuse of the license system, Teva methodically attempted to obstruct competitors for the medication Copaxone when the license will end, according to the European Payment.
发布者：BY ALBERT RONNING-ANDERSSON，转转请注明出处：https://robotalks.cn/vestager-fines-teva-eur-463-million-for-systematic-attempts-to-block-competition/
Skyports Facilities and Dubai Roadways & Transportation Authority ( RTA) have actually carried out the ritualistic ‘topping-out’ event of the DXV vertiport, which …
The silicon photonics leader Lightmatter Inc. claims it prepares to spearhead a transformation in information facility connection with the coming launch of its initial 3D co-packag…
The international humanoid robotic market got to a worth of virtually $2.37 billion in 2023, having actually expanded at a compound yearly development price (CAGR) of 40.69 percent…
Ivanhoe Electric (TSX, NYSE: IE) said the United States export credit agency is interested in lending it up to $825 million for the company’s Santa Cruz copper project in Arizona. …
